Mesa Laboratories, Inc. (MLAB) Director H Stuart Campbell Sells 989 Shares


Mesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 989 shares of the business’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $191.17, for a total transaction of $189,067.13. Following the transaction, the director now directly owns 41,527 shares of the company’s stock, valued at approximately $7,938,716.59. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.


Mesa Laboratories stock traded down $4.57 on Thursday, reaching $202.26. 128 shares of the stock were exchanged, compared to its average volume of 30,547. The firm has a market cap of $781.68 million, a price-to-earnings ratio of 32.73 and a beta of 0.47. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.85 and a quick ratio of 1.32. Mesa Laboratories, Inc. has a twelve month low of $122.35 and a twelve month high of $211.55.

Get Mesa Laboratories alerts:

Mesa Laboratories (NASDAQ:MLAB) last released its earnings results on Tuesday, June 5th. The medical instruments supplier reported $1.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.84 by $0.24. The firm had revenue of $26.88 million during the quarter, compared to analyst estimates of $25.40 million. Mesa Laboratories had a negative net margin of 3.08% and a positive return on equity of 12.93%. sell-side analysts expect that Mesa Laboratories, Inc. will post 6.84 earnings per share for the current year.


The company also recently announced a quarterly dividend, which was paid on Friday, June 15th. Shareholders of record on Thursday, May 31st were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Wednesday, May 30th. Mesa Laboratories’s dividend payout ratio is 10.36%.

Institutional investors have recently added to or reduced their stakes in the business. MetLife Investment Advisors LLC acquired a new position in Mesa Laboratories during the 4th quarter worth $183,000. Capital Analysts LLC increased its holdings in shares of Mesa Laboratories by 83.7% during the 4th quarter. Capital Analysts LLC now owns 1,580 shares of the medical instruments supplier’s stock worth $271,000 after purchasing an additional 720 shares during the period. Cambridge Investment Research Advisors Inc. bought a new position in shares of Mesa Laboratories during the 1st quarter worth about $255,000. Envestnet Asset Management Inc. increased its holdings in shares of Mesa Laboratories by 30.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,051 shares of the medical instruments supplier’s stock worth $304,000 after purchasing an additional 476 shares during the period. Finally, Keybank National Association OH increased its holdings in shares of Mesa Laboratories by 13.2% during the 4th quarter. Keybank National Association OH now owns 3,850 shares of the medical instruments supplier’s stock worth $479,000 after purchasing an additional 450 shares during the period. 73.68% of the stock is owned by hedge funds and other institutional investors.


A number of research analysts have weighed in on MLAB shares. Zacks Investment Research raised shares of Mesa Laboratories from a “sell” rating to a “hold” rating in a research report on Wednesday, February 28th. BidaskClub raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research report on Thursday, March 15th. Finally, ValuEngine raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd.

Mesa Laboratories Company Profile


Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Insider Buying and Selling by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Leave a Reply

Your email address will not be published. Required fields are marked *